{"id":"NCT00706563","sponsor":"GlaxoSmithKline","briefTitle":"A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults","officialTitle":"A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in People Aged 18 Years or Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07-07","primaryCompletion":"2008-07-30","completion":"2008-07-30","firstPosted":"2008-06-27","resultsPosted":"2009-08-25","lastUpdate":"2018-08-17"},"enrollment":120,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluarix™","otherNames":["Influsplit"]}],"arms":[{"label":"Fluarix Adult Group","type":"EXPERIMENTAL"},{"label":"Fluarix Elderly Group","type":"EXPERIMENTAL"}],"summary":"This study is designed to test the immunogenicity and reactogenicity of the Fluarix™/Influsplit SSW® influenza vaccine containing the influenza strains recommended for the 2008-2009 season.","primaryOutcome":{"measure":"Hemagglutination Inhibition (HI) Antibody Titer","timeFrame":"At Day 0 and 21","effectByArm":[{"arm":"Fluarix Adult Group","deltaMin":13.6,"sd":null},{"arm":"Fluarix Elderly Group","deltaMin":11.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":5,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":61},"commonTop":["Pain","Redness","Induration","Swelling","Myalgia"]}}